Vaxart Dividend
Dividend criteria checks 0/6
Vaxart does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.47 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Here's Why Vaxart (NASDAQ:VXRT) Must Use Its Cash Wisely
Nov 08Vaxart (NASDAQ:VXRT) Will Have To Spend Its Cash Wisely
Jun 30Vaxart: The Market Still Isn't Buying Oral Vaccine Thesis
Sep 09Ray Stapleton joins Vaxart as CTO
Aug 31Vaxart shareholders approve proposal to increase number of shares
Aug 05Vaxart continues to lobby shareholders to vote to increase number of shares
Jul 29Vaxart oral COVID-19 pill vaccine candidate induces long-lasting antibodies against SARS-CoV-2
Jul 20Vaxart says recent CRO agreement 'may be integral' to oral COVID vaccine success
Jul 07Vaxart: A Unique Vaccine Concern
Jun 14Vaxart: A Speculative Biotech With Potential As Covid-19 Play And Oral Vaccine Platform
Feb 26Vaxart: Investment Case For An Oral COVID Vaccine Not So Hard To Swallow
Dec 09Vaxart: Differentiated Covid Oral Route Remains Viable
Nov 16Vaxart: A Close Look At Their COVID-19 Oral Tablet Vaccine Program
Oct 30Vaxart: An Update
Oct 02Companies Like Vaxart (NASDAQ:VXRT) Are In A Position To Invest In Growth
Aug 25Vaxart: World's First Oral COVID Vaccine In Development
Jul 25FDA is set to decline new emergency use authorizations for COVID-19 vaccines
May 26We're Hopeful That Vaxart (NASDAQ:VXRT) Will Use Its Cash Wisely
May 11Enrollment underway in Vaxart's early-stage norovirus trial in elderly population
May 07Vaxart EPS misses by $0.04, misses on revenue
May 03Plucky Underdog Vaxart Still Banging Drum For Oral Vaccination
Apr 30Vaxart is soaring on more than 10 times the two-month average volume
Apr 27Shareholders Are Thrilled That The Vaxart (NASDAQ:VXRT) Share Price Increased 231%
Mar 03Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if VXRT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if VXRT's dividend payments have been increasing.
Dividend Yield vs Market
Vaxart Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (VXRT) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (VXRT) | n/a |
Notable Dividend: Unable to evaluate VXRT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate VXRT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate VXRT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as VXRT has not reported any payouts.